M&T Bank Corp decreased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 5,471 shares of the medical technology company’s stock after selling 231 shares during the quarter. M&T Bank Corp’s holdings in Teleflex were worth $1,361,000 as of its most recent SEC filing.
Other large investors also recently made changes to their positions in the company. Toronto Dominion Bank raised its stake in Teleflex by 14.5% during the second quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock valued at $115,000 after buying an additional 70 shares during the last quarter. Advisory Services Network LLC raised its stake in Teleflex by 933.8% during the second quarter. Advisory Services Network LLC now owns 827 shares of the medical technology company’s stock valued at $172,000 after buying an additional 747 shares during the last quarter. Cornerstone Capital Management Holdings LLC. purchased a new position in Teleflex during the second quarter valued at $175,000. Quantitative Systematic Strategies LLC purchased a new position in Teleflex during the fourth quarter valued at $228,000. Finally, Checchi Capital Advisers LLC purchased a new position in Teleflex during the fourth quarter valued at $230,000. Institutional investors and hedge funds own 89.22% of the company’s stock.
TFX has been the subject of a number of recent research reports. Morgan Stanley lifted their price objective on Teleflex from $274.00 to $290.00 and gave the company an “equal weight” rating in a research note on Friday, November 3rd. Jefferies Group boosted their price target on Teleflex from $270.00 to $295.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Leerink Swann restated a “buy” rating and issued a $321.00 price target (up previously from $307.00) on shares of Teleflex in a research note on Tuesday, January 30th. Deutsche Bank cut Teleflex from a “buy” rating to a “hold” rating and set a $251.00 price target for the company. in a research note on Tuesday, November 14th. Finally, Stephens restated a “buy” rating and issued a $300.00 price target on shares of Teleflex in a research note on Thursday, January 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $283.89.
In related news, Director Stephen K. M.D. Klasko sold 200 shares of the company’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $276.44, for a total transaction of $55,288.00. Following the completion of the sale, the director now owns 8,080 shares in the company, valued at $2,233,635.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director George Babich, Jr. sold 2,500 shares of the company’s stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $263.38, for a total value of $658,450.00. Following the sale, the director now owns 10,583 shares of the company’s stock, valued at approximately $2,787,350.54. The disclosure for this sale can be found here. In the last quarter, insiders have sold 10,100 shares of company stock valued at $2,671,994. 2.39% of the stock is owned by company insiders.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.